Trump Administration to Pilot 340B Rebate Model Next Year

Trump administration to pilot 340B rebate model next year

The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs. Hospitals say 340B is a lifeline, while drugmakers say hospitals have abused the program.

Trump administration proposes pilot initiative to address controversy over 340B drug discount program

Hospital groups complained that any move toward offering rebates instead of upfront discounts would financially squeeze some participants.

HHS announces new 340B Rebate Model Pilot Program

The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B-covered entities.  The notice said HHS’ Health Resources and Services Administration’s Office of Pharmacy Affairs, which currently oversees the 340B Drug Pricing Program, is inviting certain drug manufacturers to a…

HRSA announces application process for the 340B Rebate Model Pilot Program

WASHINGTON — The Health Resources and Services Administration (HRSA) announced the availability of a voluntary 340B Rebate Model Pilot Program for drugs on the CMS Medicare Drug Price Negotiation Selected Drug List for year 2026 from qualifying manufacturers meeting specific criteria.HRSA is introducing this pilot program to test the rebate model on these drugs in a methodical and thoughtful approach to ensure a fair and transparent 340B rebate …

HRSA Proposes 340B Rebate Model Pilot for Narrow Set of Drugs Under Strict Conditions - 340B Report

The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...] The post HRSA Proposes 340B Rebate Model Pilot for Narrow Set of Drugs Under Strict Conditions appeared first on 340B Report.